Your browser doesn't support javascript.
loading
Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation.
Kakuda, Thomas N; Leopold, Lorant; Timmers, Maarten; Van De Casteele, Tom; Hillewaert, Vera; Tomaka, Frank L; Hoetelmans, Richard M W.
Affiliation
  • Kakuda TN; Janssen Research & Development, LLC, Titusville, NJ, USA, Janssen Research & Development, and Janssen Infectious Diseases BVBA, Beerse, Belgium.
Int J Clin Pharmacol Ther ; 52(9): 805-16, 2014 Sep.
Article in En | MEDLINE | ID: mdl-25109510
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Anti-HIV Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pharmacol Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Anti-HIV Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pharmacol Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Document type: Article Affiliation country: Country of publication: